Literature DB >> 3307619

Antimicrobial substance from a human Lactobacillus strain.

M Silva, N V Jacobus, C Deneke, S L Gorbach.   

Abstract

Lactobacillus sp. strain GG, which was isolated from the feces of a normal person, produced a substance with potent inhibitory activity against a wide range of bacterial species. It inhibited anaerobic bacteria (Clostridium spp., Bacteroides spp., Bifidobacterium spp.), members of the family Enterobacteriaceae, Pseudomonas spp. Staphylococcus spp., and Streptococcus spp., as demonstrated by a microbiological assay; however, it did not inhibit other lactobacilli. The inhibitory activity occurred between pH 3 and 5 and was heat stable. Bactericidal activity against Escherichia coli was demonstrated at a dilution of 1:128. The inhibitory substance was distinct from lactic and acetic acids. It had a low molecular weight (less than 1,000) and was soluble in acetone-water (10:1). Because of these characteristics, the inhibitory material could not be considered a bacteriocin; it most closely resembled a microcin, which has been associated previously with members of the family Enterobacteriaceae.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3307619      PMCID: PMC174909          DOI: 10.1128/AAC.31.8.1231

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  12 in total

1.  A new family of low molecular weight antibiotics from enterobacteria.

Authors:  C Asensio; J C Pérez-Díaz
Journal:  Biochem Biophys Res Commun       Date:  1976-03-08       Impact factor: 3.575

2.  Beneficial effects of administration of Lactobacillus acidophilus in diarrheal and other intestinal disorders.

Authors:  C BECK; H NECHELES
Journal:  Am J Gastroenterol       Date:  1961-05       Impact factor: 10.864

3.  Antibacterial activity associated with Lactobacillus acidophilus.

Authors:  J G VINCENT; R C VEOMETT; R F RILEY
Journal:  J Bacteriol       Date:  1959-10       Impact factor: 3.490

4.  Radial diffusion in gel for micro determination of enzymes. II. Plasminogen activator, elastase, and nonspecific proteases.

Authors:  G F Schumacher; W B Schill
Journal:  Anal Biochem       Date:  1972-07       Impact factor: 3.365

5.  Acidolin: an antibiotic produced by Lactobacillus acidophilus.

Authors:  I Y Hamdan; E M Mikolajcik
Journal:  J Antibiot (Tokyo)       Date:  1974-08       Impact factor: 2.649

Review 6.  Bacteriocins of gram-positive bacteria.

Authors:  J R Tagg; A S Dajani; L W Wannamaker
Journal:  Bacteriol Rev       Date:  1976-09

7.  Purification and characterization of the Lactobacillus acidophilus bacteriocin lactacin B.

Authors:  S F Barefoot; T R Klaenhammer
Journal:  Antimicrob Agents Chemother       Date:  1984-09       Impact factor: 5.191

8.  Interactions among lactobacilli and man.

Authors:  M L Speck
Journal:  J Dairy Sci       Date:  1976-02       Impact factor: 4.034

9.  Alterations in fecal microflora enzymes related to diet, age, lactobacillus supplements, and dimethylhydrazine.

Authors:  B Goldin; S L Gorbach
Journal:  Cancer       Date:  1977-11       Impact factor: 6.860

10.  Attachment of enterotoxigenic Escherichia coli to human intestinal cells.

Authors:  C F Deneke; K McGowan; G M Thorne; S L Gorbach
Journal:  Infect Immun       Date:  1983-03       Impact factor: 3.441

View more
  99 in total

Review 1.  Probiotics and prebiotics: can regulating the activities of intestinal bacteria benefit health?

Authors:  G T Macfarlane; J H Cummings
Journal:  BMJ       Date:  1999-04-10

2.  In vivo effects of bifidobacteria and lactoferrin on gut endotoxin concentration and mucosal immunity in Balb/c mice.

Authors:  Elizabeth A Griffiths; Linda C Duffy; Floyd L Schanbacher; Haiping Qiao; Diane Dryja; Allen Leavens; Jon Rossman; Gary Rich; Douglas Dirienzo; Pearay L Ogra
Journal:  Dig Dis Sci       Date:  2004-04       Impact factor: 3.199

3.  NATURAL ANTIMICROBIALS AND THEIR ROLE IN VAGINAL HEALTH: A SHORT REVIEW.

Authors:  S E Dover; A A Aroutcheva; S Faro; M L Chikindas
Journal:  Int J Probiotics Prebiotics       Date:  2008

4.  Probiotics and Gastrointestinal Disease: Clinical Evidence and Basic Science.

Authors:  Elaine O Petrof
Journal:  Antiinflamm Antiallergy Agents Med Chem       Date:  2009-09-01

5.  pH-, Lactic acid-, and non-lactic acid-dependent activities of probiotic Lactobacilli against Salmonella enterica Serovar Typhimurium.

Authors:  Domitille Fayol-Messaoudi; Cédric N Berger; Marie-Hélène Coconnier-Polter; Vanessa Liévin-Le Moal; Alain L Servin
Journal:  Appl Environ Microbiol       Date:  2005-10       Impact factor: 4.792

Review 6.  The front line of enteric host defense against unwelcome intrusion of harmful microorganisms: mucins, antimicrobial peptides, and microbiota.

Authors:  Vanessa Liévin-Le Moal; Alain L Servin
Journal:  Clin Microbiol Rev       Date:  2006-04       Impact factor: 26.132

7.  Survival of Lactobacillus species (strain GG) in human gastrointestinal tract.

Authors:  B R Goldin; S L Gorbach; M Saxelin; S Barakat; L Gualtieri; S Salminen
Journal:  Dig Dis Sci       Date:  1992-01       Impact factor: 3.199

8.  Signalling mechanisms involved in the induction of inducible nitric oxide synthase by Lactobacillus rhamnosus GG, endotoxin, and lipoteichoic acid.

Authors:  Riku Korhonen; Riitta Korpela; Eeva Moilanen
Journal:  Inflammation       Date:  2002-10       Impact factor: 4.092

9.  Characterization of a stress tolerance-defective mutant of Lactobacillus rhamnosus LRB.

Authors:  Saswati Biswas; Andrew Keightley; Indranil Biswas
Journal:  Mol Oral Microbiol       Date:  2019-06-07       Impact factor: 3.563

10.  In vitro anti-Helicobacter pylori activity of the probiotic strain Bacillus subtilis 3 is due to secretion of antibiotics.

Authors:  I V Pinchuk; P Bressollier; B Verneuil; B Fenet; I B Sorokulova; F Mégraud; M C Urdaci
Journal:  Antimicrob Agents Chemother       Date:  2001-11       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.